← back to search

Minh Tam Truong

Boston University · US
Area of research
Otorhinolaryngology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Head and Neck Cancer Studies, Advanced Radiotherapy Techniques, Head and Neck Surgical Oncology, and Radiomics and Machine Learning in Medical Imaging.
h-index
27
citations
2,670
works
135
NIH funding
primary concept
Medicine
email

Recent publications

Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial
The Lancet Oncology 2024cited by 52position: middledoi
Somatic Activating <i>ESR1</i> Mutation in an Aggressive Prolactinoma
The Journal of Clinical Endocrinology & Metabolism 2024cited by 8position: middledoi
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
Journal of Clinical Oncology 2021cited by 366position: middledoi
Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images
BMC Cancer 2021cited by 25position: middledoi
Longitudinal Outcomes of Medical Student Research Mentorship: a 15-Year Analysis of the Radiation Oncology Mentorship Initiative
Journal of Cancer Education 2021cited by 11position: middledoi
Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma
European Radiology 2020cited by 49position: middledoi
Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary
Head & Neck 2020cited by 28position: middledoi
Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria
Head & Neck 2020cited by 23position: middledoi
Prediction of the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma by FDG-PET imaging dataset using deep learning analysis: A hypothesis-generating study
European Journal of Radiology 2020cited by 23position: middledoi
US Radiation Oncologists (Re)Defined: An American Society for Radiation Oncology Scope of Practice Study
International Journal of Radiation Oncology*Biology*Physics 2020cited by 18position: middledoi
Comparing surgical and nonsurgical larynx‐preserving treatments with total laryngectomy for locally advanced laryngeal cancer
Cancer 2019cited by 66position: lastdoi
Safety and disease control achieved with the addition of nivolumab (Nivo) to chemoradiotherapy (CRT) for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG Foundation 3504.
Journal of Clinical Oncology 2019cited by 22position: middledoi
Presentation, Treatment, and Outcomes of Vulnerable Populations With Esophageal Cancer Treated at a Safety-Net Hospital
Seminars in Thoracic and Cardiovascular Surgery 2019cited by 18position: middledoi
The American Society for Radiation Oncology 2017 Radiation Oncologist Workforce Study
International Journal of Radiation Oncology*Biology*Physics 2018cited by 102position: middledoi
Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database
Journal of the American Academy of Dermatology 2018cited by 72position: middledoi
Radiotherapy Utilization and Fractionation Patterns During the First Course of Cancer Treatment in the United States From 2004 to 2014
Journal of the American College of Radiology 2018cited by 56position: lastdoi
Safety evaluation of nivolumab (Nivo) concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504.
Journal of Clinical Oncology 2018cited by 29position: middledoi
External beam radiation for localized periocular amyloidosis: a case series
Orbit 2018cited by 19position: middledoi
Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden
The Annals of Thoracic Surgery 2018cited by 17position: middledoi
Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection
Head & Neck 2017cited by 27position: lastdoi
Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following Resection
JAMA Dermatology 2017cited by 26position: lastdoi
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522
International Journal of Radiation Oncology*Biology*Physics 2016cited by 40position: firstdoi
Analysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelines
Practical Radiation Oncology 2015cited by 31position: lastdoi
FDG PET Metabolic Tumor Volume Segmentation and Pathologic Volume of Primary Human Solid Tumors
American Journal of Roentgenology 2014cited by 93position: middledoi
FDG PET/CT in the Management of Nasopharyngeal Carcinoma
American Journal of Roentgenology 2014cited by 61position: middledoi
The influence of limited English proficiency on outcome in patients treated with radiotherapy for head and neck cancer
Patient Education and Counseling 2014cited by 55position: lastdoi
Medical student mentorship in radiation oncology at a single academic institution: A 10-year analysis
Practical Radiation Oncology 2014cited by 39position: middledoi
Outcomes in head and neck oncologic surgery at academic medical centers in the united states
The Laryngoscope 2013cited by 51position: lastdoi
A quantitative assessment of volumetric and anatomic changes of the parotid gland during intensity-modulated radiotherapy for head and neck cancer using serial computed tomography
Medical dosimetry 2013cited by 12position: lastdoi
<sup>18</sup>F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging
Journal of Nuclear Medicine 2012cited by 217position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Muhammad M. Qureshi · Boston University13 papers (2012–2021)Gustavo Mercier · Brigham and Women's Hospital6 papers (2012–2021)Rathan M. Subramaniam · Indira Gandhi Institute of Child Health6 papers (2012–2021)Scharukh Jalisi · Beth Israel Deaconess Medical Center6 papers (2012–2019)Osamu Sakai · Massachusetts Eye and Ear Infirmary5 papers (2012–2021)Quynh‐Thu Le · Stanford University4 papers (2016–2021)Kimberley S. Mak · Boston University4 papers (2017–2021)Gregory A. Grillone · Boston University4 papers (2012–2019)Debjani Sahni · Boston University3 papers (2017–2018)Praveen Sridhar · Mount Sinai Hospital3 papers (2014–2019)Sara K. Meibom · Boston University3 papers (2020–2021)V. Carlota Andreu‐Arasa · Boston University3 papers (2020–2021)Loren K. Mell · Johns Hopkins Medicine3 papers (2018–2021)Sagar A. Patel · Emory University3 papers (2017–2019)Trevor J. Royce · Hewlett-Packard (United States)3 papers (2018–2020)Paul B. Romesser · International Drug Development3 papers (2012–2014)Noriyuki Fujima · Hokkaido University3 papers (2020–2021)Richard C. Jordan · Université de franche-comté3 papers (2018–2021)Dukagjin Blakaj · U-M Rogel Cancer Center3 papers (2018–2021)Christina S. Kong · Stanford University3 papers (2018–2021)